Rare lephants
Screener

BioCryst Pharmaceuticals, Inc.

BCRX ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
4 Sep 2, 2026 PRIMARY DOCUMENT
4 Sep 2, 2026 PRIMARY DOCUMENT
4 Sep 2, 2026 PRIMARY DOCUMENT
4 Sep 2, 2026 PRIMARY DOCUMENT
4 Sep 2, 2026 PRIMARY DOCUMENT
SCHEDULE 13G/A Aug 14, 2026
SCHEDULE 13G Aug 7, 2026
S-8 Aug 5, 2026 FORM S-8
10-Q Aug 5, 2026 10-Q
8-K Aug 5, 2026 FORM 8-K
8-K/A Aug 4, 2026 FORM 8-K/A
8-K Jun 29, 2026 FORM 8-K
4 Jun 15, 2026 PRIMARY DOCUMENT
4 Jun 15, 2026 PRIMARY DOCUMENT
4 Jun 15, 2026 PRIMARY DOCUMENT
4 Jun 15, 2026 PRIMARY DOCUMENT
4 Jun 15, 2026 PRIMARY DOCUMENT
4 Jun 15, 2026 PRIMARY DOCUMENT
4 Jun 15, 2026 PRIMARY DOCUMENT
4 Jun 15, 2026 PRIMARY DOCUMENT
4 Jun 15, 2026 PRIMARY DOCUMENT
8-K Jun 12, 2026 FORM 8-K
4 Jun 2, 2026 PRIMARY DOCUMENT
4 Jun 2, 2026 PRIMARY DOCUMENT
4 Jun 2, 2026 PRIMARY DOCUMENT
← Newer Page 1 of 77 · 1920 filings Older →